YOUR BROWSER IS OUT-OF-DATE.
We have detected that you are using an outdated browser. Our service may not work properly for you. We recommend upgrading or switching to another browser.
Elżbieta Wieczorek, DSc, PhD, Eng
Email: elzbieta.wieczorek@pwr.edu.pl
Unit: Faculty of Chemistry » Department of Biochemistry, Molecular Biology and Biotechnology
ul. Gdańska 7/9, 50-344 Wrocław
building F-4, room C-16
phone +48 71 320 6226
Research interest
- Understanding the structure, function and post-translational modifications of human transthyretin;
- Studying the structural changes and changes in physicochemical properties of transthyretin that occur in the process leading to amyloid formation.
- Understanding the role of human transthyretin in bio-mineralization and in response to cellular stress.
- To studying the relationship between structural changes in transthyretin and the disease processes in which they occur.
Recent papers
Wieczorek E, Wygralak Z, Kędracka-Krok S, Bezara P, Bystranowska D, Dobryszycki P, Ożyhar A. Deep blue autofluorescence reflects the oxidation state of human transthyretin. Redox Biol. 2022 Aug 9;56:102434. doi: 10.1016/j.redox.2022.102434. Epub ahead of print. PMID: 35987087; PMCID: PMC9411673.
Wieczorek, E.; Ożyhar, A. Transthyretin: From structural stability to osteoarticular and cardiovascular diseases. Cells 2021, 10, doi:10.3390/cells10071768. PMID: 34359938
Wieczorek, E.; Bezara, P.; Ożyhar, A. Deep blue autofluorescence reveals the instability of human transthyretin. Int. J. Biol. Macromol. 2021, 191, 492–499, doi:10.1016/j.ijbiomac.2021.09.107. PMID: 34562536
Wieczorek, E.; Kędracka-Krok, S.; Bystranowska, D.; Ptak, M.; Wiak, K.; Wygralak, Z.; Jankowska, U.; Ożyhar, A. Destabilisation of the structure of transthyretin is driven by Ca2+. Int. J. Biol. Macromol. 2021, 166, 409–423, doi:10.1016/j.ijbiomac.2020.10.199. PMID: 33129902
Wieczorek, E.; Chitruń, A.; Ożyhar, A. Destabilised human transthyretin shapes the morphology of calcium carbonate crystals. Biochim. Biophys. Acta - Gen. Subj. 2019, 1863, 313–324, doi:10.1016/j.bbagen.2018.10.017. PMID: 30394286
Wieczorek, E.; Kędracka–Krok, S.; Sołtys, K.; Jankowska, U.; Hołubowicz, R.; Seliga, J.; Ożyhar, A. Is Transthyretin a Regulator of Ubc9 SUMOylation? PLoS ONE 2016, 11, e0160536. PMID: 27501389
